# Sonodynamic Therapy With ExAblate System in Glioblastoma Patients

> **NCT04845919** · PHASE2 · COMPLETED · sponsor: **Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta** · enrollment: 5 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** 5-Aminolevulinic Acid

## Key facts

- **NCT ID:** NCT04845919
- **Lead sponsor:** Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-22
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04845919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04845919, "Sonodynamic Therapy With ExAblate System in Glioblastoma Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04845919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*